MARKET

FRTX

FRTX

Fresh Tracks Therapeutics Inc
OTCPK
0.930
+0.005
+0.55%
Closed 14:30 06/14 EDT
OPEN
0.930
PREV CLOSE
0.925
HIGH
0.930
LOW
0.930
VOLUME
702
TURNOVER
653
52 WEEK HIGH
3.140
52 WEEK LOW
0.450
MARKET CAP
5.56M
P/E (TTM)
-0.8811
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at FRTX last week (0603-0607)?
Weekly Report · 4d ago
Monopar Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern about the company's prospects. Recent notable insider transactions for penny stocks include Grove Collaborative Holdings, Inc. And Fresh Tracks Therapeutics. The Dow Jones index closed higher by around 575 points on Friday.
Benzinga · 06/03 11:41
Weekly Report: what happened at FRTX last week (0527-0531)?
Weekly Report · 06/03 09:32
Weekly Report: what happened at FRTX last week (0520-0524)?
Weekly Report · 05/27 09:32
Clover Health Investments And 2 Other Stocks Under $1 Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern about the company's prospects. Fresh Tracks Therapeutics, Inc. And MultiPlan Corporation have had recent notable insider transactions for penny stocks. The Dow Jones index closed lower on Monday. Clover Health Investments, Corp. Is one of the companies involved in the trade.
Benzinga · 05/21 12:40
Weekly Report: what happened at FRTX last week (0513-0517)?
Weekly Report · 05/20 09:31
Weekly Report: what happened at FRTX last week (0506-0510)?
Weekly Report · 05/13 09:33
Weekly Report: what happened at FRTX last week (0429-0503)?
Weekly Report · 05/06 09:35
More
About FRTX
Fresh Tracks Therapeutics, Inc. is a clinical-stage pharmaceutical company. The Company is engaged in transforming patient lives through the development of differentiated prescription therapeutics. Its pipeline is focused on providing existing treatment paradigms and features several new chemical entities that inhibit novel targets with potential for autoimmune, inflammatory, and other debilitating diseases. The Company’s strategy is exploring therapies by identifying, pursuing, and developing therapeutics that can help people struggling with autoimmune, inflammatory, and other debilitating diseases. Its pipeline includes FRTX-02, FRTX-10, Next-Generation Kinase Inhibitors and FRTX-03. FRTX-02 is a potential Oral DYRK1A Inhibitor for the treatment of autoimmune and inflammatory diseases. Its FRTX-10 is a covalent Stimulator of Interferon Genes (STING) inhibitor candidate for the potential treatment of autoimmune, inflammatory, and rare genetic diseases.

Webull offers Fresh Tracks Therapeutics Inc stock information, including OTCPK: FRTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FRTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FRTX stock methods without spending real money on the virtual paper trading platform.